查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1594475

神經調節劑的全球市場：按產品、應用和最終用戶分類 - 2025-2030 年預測

Neuromodulation Devices Market by Product (Deep Brain Stimulators, Sacral Nerve Stimulators, Spinal Cord Stimulators), Application (Neurological Disorders, Pain Management, Respiratory Disorders), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年神經調節劑市值為86.6億美元，預計2024年將達到97.9億美元，複合年成長率為13.54%，到2030年將達到210.7億美元。

神經調節器是先進的技術設備，用於透過將電劑或藥劑直接輸送到特定的神經目標來調節神經活動。這些設備具有廣泛的應用，可以解決慢性疼痛、癲癇、帕金森氏症和憂鬱症疾病。這些對於滿足傳統治療方法不足以滿足的未滿足的醫療需求至關重要。對這些設備的需求源於它們能夠提供微創、有針對性的解決方案，改善患者的生活品質，並提供手術和長期藥物的替代方案。主要最終用戶包括醫院、診所和專業研究中心，凸顯了其在醫療保健環境中的廣泛適用性。市場開拓受到以下因素的顯著影響：神經系統疾病的日益普及、提高設備有效性和安全性的技術進步、以及已開發國家和新興經濟體的醫療投資意識的提高。機會包括利用人工智慧進行個人化神經調節治療，並將其應用擴展到心理健康治療。建議包括增強設備的便攜性和電池壽命以提高用戶便利性，以及擴大與醫療保健提供者的策略夥伴關係以加快採用率。然而，高昂的設備成本、嚴格的監管要求以及潛在的設備相關併發症等挑戰可能會阻礙市場擴張。醫療保健專業人員的技術技能的限制也會影響設備的使用率。因此，制定培訓計劃和簡化設備介面非常重要。創新的重點是改進微創技術、探索無線神經調節以及整合即時資料分析以改善結果。由於技術的不斷進步和對以患者為中心的治療解決方案的日益關注，該市場充滿活力。高科技公司和醫療機構之間的合作對於駕馭不斷變化的格局和推動突破性技術的研究至關重要，這些技術將塑造神經調節療法的未來。

主要市場統計
基準年[2023] 86.6億美元
預測年份 [2024] 97.9億美元
預測年份 [2030] 210.7億美元
複合年成長率（%） 13.54%

市場動態：快速發展的神經調節劑市場的關鍵市場洞察

供需的動態交互作用正在改變神經調節劑市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 神經系統疾病和損傷的盛行率上升
    • 對神經調節和神經刺激技術的日益關注
    • 擴大神經調節的應用
  • 市場限制因素
    • 神經調節程序的高成本
  • 市場機會
    • 政府對神經系統疾病研究的支持
    • 新型神經調節劑的開發
  • 市場挑戰
    • 嚴格的法律規範和漫長的核准流程
    • 全球專業工程師短缺

波特五力：駕馭神經調節劑市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解神經調節劑市場的外部影響

外部宏觀環境因素在塑造神經調節劑市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助企業預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解神經調節劑市場的競爭格局

對神經調節劑市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣神經調節器市場供應商的績效評估

FPNV定位矩陣是評估神經調節器市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃神經調節劑市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對神經調節劑市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 神經系統疾病和損傷的盛行率增加
      • 對神經調節和神經刺激技術的日益關注
      • 擴大神經調節的應用
    • 抑制因素
      • 神經調節程序的高成本
    • 機會
      • 政府對神經系統疾病研究的支持
      • 新型神經調節劑的開發
    • 任務
      • 嚴格的法規結構和漫長的核准流程
      • 全球都缺乏專業技術人員
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章神經調節劑市場：依產品

  • 深層腦部刺激器
  • 薦骨神經刺激器
  • 脊髓刺激設備
  • 經顱磁刺激器
  • 迷走神經刺激設備

第7章神經調節劑市場：依應用分類

  • 神經系統疾病
  • 疼痛管理
  • 呼吸系統疾病

第8章神經調節器市場：依最終用戶分類

  • 醫院
  • 專科診所及門診中心

第9章美洲神經調節劑市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太神經調節劑市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲/中東/非洲神經調節劑市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Aleva Neurotherapeutics SA
  • Avanos Medical, Inc.
  • Axonics, Inc.
  • B. Braun SE
  • Beijing PINS Medical Co., Ltd.
  • Bioventus
  • Boston Scientific Corporation
  • LivaNova PLC
  • Medtronic PLC
  • Nevro Corp.
  • Second Sight Medical Products Inc.
  • SPR Therapeutics, Inc.
  • Stimwave LLC
  • SunMed
Product Code: MRR-205091A88963

The Neuromodulation Devices Market was valued at USD 8.66 billion in 2023, expected to reach USD 9.79 billion in 2024, and is projected to grow at a CAGR of 13.54%, to USD 21.07 billion by 2030.

Neuromodulation devices are advanced technological equipment employed to modulate nerve activity by delivering electrical or pharmaceutical agents directly to specific neurological targets. The scope of these devices spans a variety of applications, addressing conditions such as chronic pain, epilepsy, Parkinson's disease, and depression. They are vital in bridging unmet medical needs where traditional therapies fall short. The necessity for these devices arises from their ability to provide targeted solutions with minimal invasiveness, improving patients' quality of life and offering alternatives to surgery or long-term medication use. Key end-users include hospitals, clinics, and specialized research centers, emphasizing their broad applicability in healthcare settings. Market growth is significantly influenced by factors such as increasing prevalence of neurological disorders, technological advancements enhancing device efficacy and safety, and rising awareness coupled with healthcare investments in developed and emerging economies. Opportunities lie in leveraging artificial intelligence for personalized neuromodulation therapies and expanding applications in mental health treatment. Recommendations include enhancing device portability and battery life to improve user convenience and expanding strategic partnerships with healthcare providers to accelerate adoption rates. However, challenges such as high device costs, stringent regulatory requirements, and potential device-related complications can hinder market expansion. Limitations in technical skillsets among healthcare professionals may also affect device utilization. Hence, fostering training programs and simplifying device interfaces are critical. Innovation should center on refining minimally invasive techniques, exploring wireless neuromodulation, and integrating real-time data analytics for improved outcomes. This market is dynamic, driven by continuous technological progress and a growing emphasis on patient-centered therapeutic solutions. Collaborations between tech companies and healthcare institutions are crucial to navigate the evolving landscape, enabling research into breakthrough technologies that can shape the future of neuromodulatory therapies.

KEY MARKET STATISTICS
Base Year [2023] USD 8.66 billion
Estimated Year [2024] USD 9.79 billion
Forecast Year [2030] USD 21.07 billion
CAGR (%) 13.54%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Neuromodulation Devices Market

The Neuromodulation Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of neurological disorders and nerve injuries
    • Growing focus on neuromodulation & neurostimulation technologies
    • Expanding applications of neuromodulation
  • Market Restraints
    • High cost of neuromodulation procedures
  • Market Opportunities
    • Government support for research on neurological disorders
    • Development of novel neuromodulation devices
  • Market Challenges
    • Stringent regulatory frameworks and time-consuming approval processes
    • Lack of technical expertise across the globe

Porter's Five Forces: A Strategic Tool for Navigating the Neuromodulation Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Neuromodulation Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Neuromodulation Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Neuromodulation Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Neuromodulation Devices Market

A detailed market share analysis in the Neuromodulation Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Neuromodulation Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Neuromodulation Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Neuromodulation Devices Market

A strategic analysis of the Neuromodulation Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Neuromodulation Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aleva Neurotherapeutics SA, Avanos Medical, Inc., Axonics, Inc., B. Braun SE, Beijing PINS Medical Co., Ltd., Bioventus, Boston Scientific Corporation, LivaNova PLC, Medtronic PLC, Nevro Corp., Second Sight Medical Products Inc., SPR Therapeutics, Inc., Stimwave LLC, and SunMed.

Market Segmentation & Coverage

This research report categorizes the Neuromodulation Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Deep Brain Stimulators, Sacral Nerve Stimulators, Spinal Cord Stimulators, Transcranial Magnetic Stimulators, and Vagus Nerve Stimulators.
  • Based on Application, market is studied across Neurological Disorders, Pain Management, and Respiratory Disorders.
  • Based on End User, market is studied across Hospitals and Specialty Clinics & Ambulatory Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of neurological disorders and nerve injuries
      • 5.1.1.2. Growing focus on neuromodulation & neurostimulation technologies
      • 5.1.1.3. Expanding applications of neuromodulation
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of neuromodulation procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Government support for research on neurological disorders
      • 5.1.3.2. Development of novel neuromodulation devices
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory frameworks and time-consuming approval processes
      • 5.1.4.2. Lack of technical expertise across the globe
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Neuromodulation Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Deep Brain Stimulators
  • 6.3. Sacral Nerve Stimulators
  • 6.4. Spinal Cord Stimulators
  • 6.5. Transcranial Magnetic Stimulators
  • 6.6. Vagus Nerve Stimulators

7. Neuromodulation Devices Market, by Application

  • 7.1. Introduction
  • 7.2. Neurological Disorders
  • 7.3. Pain Management
  • 7.4. Respiratory Disorders

8. Neuromodulation Devices Market, by End User

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Specialty Clinics & Ambulatory Centers

9. Americas Neuromodulation Devices Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Neuromodulation Devices Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Neuromodulation Devices Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Aleva Neurotherapeutics SA
  • 3. Avanos Medical, Inc.
  • 4. Axonics, Inc.
  • 5. B. Braun SE
  • 6. Beijing PINS Medical Co., Ltd.
  • 7. Bioventus
  • 8. Boston Scientific Corporation
  • 9. LivaNova PLC
  • 10. Medtronic PLC
  • 11. Nevro Corp.
  • 12. Second Sight Medical Products Inc.
  • 13. SPR Therapeutics, Inc.
  • 14. Stimwave LLC
  • 15. SunMed

LIST OF FIGURES

  • FIGURE 1. NEUROMODULATION DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. NEUROMODULATION DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. NEUROMODULATION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. NEUROMODULATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NEUROMODULATION DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NEUROMODULATION DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY SACRAL NERVE STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY SPINAL CORD STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY SPECIALTY CLINICS & AMBULATORY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. NEUROMODULATION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 148. NEUROMODULATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023